Vertex Pharmaceutic (VRTX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 03-2020 | 12-2019 | 09-2019 | 06-2019 | 03-2019 | |
| Sales | 1,515,107 | 1,413,244 | 949,828 | 941,293 | 858,435 |
| Cost of Goods | 162,497 | 185,054 | 131,914 | 135,740 | 95,092 |
| Gross Profit | 1,352,610 | 1,228,190 | 817,914 | 805,553 | 763,343 |
| Operating Expenses | 632,883 | 676,845 | 719,495 | 536,333 | 486,627 |
| Operating Income | 720,224 | 551,399 | 99,333 | 269,960 | 276,808 |
| Interest Expense | 14,136 | 14,247 | 14,548 | 14,837 | 14,868 |
| Other Income | -48,554 | 139,779 | -14,119 | 72,015 | 58,225 |
| Pre-tax Income | 657,534 | 676,931 | 70,666 | 327,138 | 320,165 |
| Income Tax | 54,781 | 93,707 | 13,148 | 59,711 | 51,534 |
| Net Income Continuous | 602,753 | 583,224 | 57,518 | 267,427 | 268,631 |
| Net Income | $602,753 | $583,224 | $57,518 | $267,427 | $268,631 |
| EPS Basic Total Ops | 2.32 | 2.27 | 0.22 | 1.04 | 1.05 |
| EPS Basic Continuous Ops | 2.32 | 2.27 | 0.22 | 1.04 | 1.05 |
| EPS Diluted Total Ops | 2.29 | 2.23 | 0.22 | 1.03 | 1.03 |
| EPS Diluted Continuous Ops | 2.29 | 2.23 | 0.22 | 1.03 | 1.03 |
| EBITDA(a) | $747,045 | $577,614 | $125,180 | $297,658 | $303,948 |